Application of (14)C-accelerator MS in pharmaceutical development.
about
Opportunities in low-level radiocarbon microtracing: applications and new technologyReaction phenotyping to assess victim drug-drug interaction risks.Regulatory aspects of human radiolabeled mass balance studies in oncology: concise review.An evaluation of human ADME and mass balance studies using regular or low doses of radiocarbon.Adding value through accelerator mass spectrometry-enabled first in human studies.
P2860
Application of (14)C-accelerator MS in pharmaceutical development.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Application of (14)C-accelerator MS in pharmaceutical development.
@en
type
label
Application of (14)C-accelerator MS in pharmaceutical development.
@en
prefLabel
Application of (14)C-accelerator MS in pharmaceutical development.
@en
P2860
P356
P1433
P1476
Application of (14)C-accelerator MS in pharmaceutical development.
@en
P2093
Graeme C Young
Mark Seymour
P2860
P304
P356
10.4155/BIO.15.2
P577
2015-01-01T00:00:00Z